Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.
Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.
复制标题
艾滋病毒感染中产生丁酸酯的细菌的丰度与微生物易位和免疫激活有关。
DOI:
10.1097/qad.0000000000001366
复制
发表时间:
2017-02-20
期刊:
影响因子:
--
通讯作者:
Wilson CC
中科院分区:
文献类型:
--
作者:
Dillon SM;Kibbie J;Lee EJ;Guo K;Santiago ML;Austin GL;Gianella S;Landay AL;Donovan AM;Frank DN;McCARTER MD;Wilson CC
Gut microbial translocation (MT) is a major driving force behind chronic immune activation during HIV-1 infection. HIV-1-related intestinal dysbiosis, including increases in mucosa-associated pathobionts, may influence MT and contribute to mucosal and systemic inflammation. Thus, it is critical to understand the mechanisms by which gut microbes and their metabolic products, such as butyrate, influence immune cell function during HIV-1 infection. A cross-sectional study was performed to compare the relative abundance of butyrate-producing bacterial species (BPB) in colonic biopsies and stool of untreated, chronic HIV-1 infected (n=18) and uninfected (n=14) study participants. The effect of exogenously added butyrate on gut T cell activation and HIV-1 infection was evaluated using an ex vivo human intestinal cell culture model. Species were identified in 16S ribosomal RNA sequence datasets. Ex vivo isolated lamina propria (LP) mononuclear cells were infected with CCR5-tropic HIV-1Bal, cultured with enteric Gram-negative bacteria and a range of butyrate doses, and LP T cell activation and HIV-1 infection levels measured. Relative abundance (RA) of total BPB and specifically of Roseburia intestinalis, were lower in colonic mucosa of HIV-1 infected versus uninfected subjects. In HIV-1 infected study participants, R. intestinalis RA inversely correlated with systemic indicators of MT, immune activation and vascular inflammation. Exogenous butyrate suppressed enteric Gram-negative bacteria-driven LP T cell activation and HIV-1 infection levels in vitro. Reductions in mucosal butyrate from diminished colonic BPB may exacerbate pathobiont driven gut T cell activation and HIV replication, thereby contributing to HIV-associated mucosal pathogenesis.